Tamoxifen Study

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1992
To assess the impact of tamoxifen on development of breast cancer, coronary heart disease, and bone fractures. The National Cancer Institute initiated the prevention trial under its National Surgical Adjuvant Breast and Bowel Project (NSABP). The National Heart, Lung, and Blood Institute provided support to obtain blood pressure and lipid measurements, and lipoprotein and selected coagulation factor measurements in a subsample.
Epistemonikos ID: 95d3540495c2f010788bddeaeb01ccd4955b1758
First added on: May 03, 2024